STTK: Shattuck Labs Inc Market Valuation
Shattuck Labs, Inc. (STTK) is developing advanced methods for combating oncology. This price chart reflects the impact of geopolitical risks on patent protection and component supplies, while the market capitalization stands at 0.52. ARC technology enables the simultaneous suppression of neoplasm defenses and the stimulation of an immune response. The growth strategy relies on deep scientific alliances with industry behemoths rather than mergers.
Comprehensive metric breakdowns and analytics for shattucklabs.com (STTK)
- stock price and consensus target price:
- market capitalization information:
- business book valuation details:
- debt obligations and liquidity statistics:
Total Debt to Capital Shattuck Labs, Inc.|STTK - Long-Term Debt to Capital Coefficient|Short-Term Debt to Capital Shattuck Labs|STTK - Company Aggregate Debts|Debt to Book Capitalization Ratio STTK|STTK - Company Long-Term Loans and Borrowings|Company Short-Term Debt Shattuck Labs|Quick Ratio shattucklabs.com
- business earnings and investment ratios data:
STTK - Net Profit|Future Profit Shattuck Labs, Inc.|STTK - Company Value to Net Income|Forward P/E Multiple Shattuck Labs|STTK - Growth-Adjusted Market Cap to Net Income|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization STTK|STTK - Operating profit before deduction of amortization|Earnings per share for the last twelve months Shattuck Labs|STTK - Net earnings per share for the last 12 months|Year-over-year net earnings per share growth for the last 12 months shattucklabs.com|STTK - Earnings growth in current year|Net earnings per share growth forecast for next year Shattuck Labs, Inc.
Fundamental company analysis:STTK (Shattuck Therapeutics)
Shattuck Labs, Inc. (STTK) is developing innovative proteins for immuno-oncology, where the success of the SL-172154 drug determines the business valuation. The total market capitalization trend reflects the market's assessment of these prospects through the product of the share price and the number of outstanding shares. This indicator captures value recovery phases and consolidation periods following volatile crises. Analyzing this metric allows for a comparison of the company's scale against its technological competitors. The asset belongs to the high-risk class of biotech startups.
Key competitors
argenx - Market Valuation|Market Value BNTX (BioNTech Inc.)|ABVX: Market Valuation|ADMA Corp - Market Value|Protagonist Therapeutics (PTGX) - Market Value|immunovant.com (IMVT) - Market Capitalization|Market Value Kiniksa|Grifols SA - Market Valuation|Market Capitalization ADPT|CLDX (Celldex Corp) - Market Value|Market Capitalization AUPH (Aurinia Pharmaceuticals)|Market Capitalization biocryst.com BCRX|VERA - Market Value|Market Value DNTH (Dianthus Therapeutics Inc)|Pharvaris Corp (PHVS) - Market Value|Market Valuation AbCellera Biologics Inc.|TRML (Tourmaline Bio, Inc.) - Market Capitalization|Market Capitalization precigen.com|Market Valuation PHAR (Pharming Group)|NKTR (Nektar Therapeutics Inc) - Market Value|Market Capitalization UPB (Upstream Bio Corp)|Market Capitalization Zenas Corp (ZBIO)|IMNM - Market Value|gossamerbio.com (GOSS) - Market Valuation|KalVista Pharmaceuticals, Inc. (KALV) - Market Value|Market Valuation Septerna, Inc.|Market Valuation PVLA|Market Capitalization Savara Pharma|Market Value Rigel Pharmaceuticals (RIGL)|anaptysbio.com - Market Capitalization|Market Capitalization ATXS (Astria Therapeutics, Inc.)|enGene Holdings Inc (ENGN) - Market Value|RAPT - Market Value|Market Capitalization Aerovate Therapeutics Inc JBIO|ACRS: Market Capitalization|kyvernatx.com - Market Value|TLSA (Tiziana Life Sciences Ltd) - Market Capitalization|Market Capitalization Cabaletta Bio Inc.|Market Valuation VTYX (Ventyx Bio)|Market Value THTX|Avalo Therapeutics, Inc - Market Valuation|Market Value ELDN (eledon.com)|AGEN: Market Valuation|CLYM - Market Capitalization|ZURA: Market Capitalization|Market Valuation aTyr Pharmaceuticals|Market Value Adagene Inc|Market Capitalization Ikena Oncology, Inc.|Market Valuation EQ (Equillium, Inc.)|CNTB (connectbiopharm.com) - Market Value|Market Value Immunic IMUX|Atara Biotherapeutics, Inc. - Market Value|InflaRx GmbH - Market Capitalization|XFOR - Market Capitalization|ACET: Market Capitalization|CELU (Celularity) - Market Value|Market Value INmune Bio Corp|Barinthus Biotherapeutics Corp (BRNS) - Market Capitalization|Market Valuation KZR (Kezar Life Sciences)|SABS (sabbiotherapeutics.com) - Market Value|Market Capitalization AKTX (Akari Therapeutics Plc)|Market Capitalization Enlivex Therapeutics Ltd (ENLV)|QTTB - Market Value|GOVX (GeoVax Corp) - Market Capitalization|EDSA: Market Capitalization|Market Valuation ibioinc.com|Market Valuation CARM|XTL Biopharmaceuticals Ltd (XTLB) - Market Capitalization|Market Value Bolt Biotherapeutics (BOLT)|Market Capitalization hcwbiologics.com|Aptevo Therapeutics Inc. - Market Valuation|Market Value AIM (aimimmuno.com)|ADTX: Market Valuation|GRI Bio Inc - Market Value|XORTX (XRTX) - Market Value|Vyome Therapeutics (HIND) - Market Capitalization|Market Value Revelation Biosciences|indaptusrx.com - Market Valuation|Market Capitalization SCNI|CALI (calcimedica.com) - Market Value|Market Capitalization AFMD (Affimed N.V.)|Market Capitalization Allakos Inc ALLK|HOOK - Market Value|Market Value IGMS (IGM Biosciences, Inc.)|iTeos Therapeutics, Inc. (ITOS) - Market Value|Market Valuation Ocean Biomedical Inc|TCBP (TC BioPharm (Holdings) PLC) - Market Capitalization|Market Capitalization Third Harmonic Bio Inc
